After Hours
$
724.95
Change
-0.10 -0.01%
Volume
Volume 44,576
May 26, 2023, 6:21 p.m.
Quotes are delayed by 20 min
Previous close
$ 725.00
$ 725.05
Change
+0.05 +0.0069%
Day low
Day high
$719.00
$726.77

52 week low
52 week high
$538.01
$837.55

Market cap
$78.23B
Average volume
571,953
P/E ratio
19.70
Rev. per Employee
$1.04M
EPS
36.81
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on REGN
-
Regeneron Pharmaceuticals Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Thursday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Tuesday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock rises Friday, still underperforms market
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on REGN
-
Sanofi Wins Supreme Court Patent Dispute With Amgen
- The Wall Street Journal Interactive Edition
-
For Tax Executives, More Disclosure on Global Liabilities Means More Headaches
- The Wall Street Journal Interactive Edition
-
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
- The Wall Street Journal Interactive Edition
-
CEO Pay Packages Fell Sharply in 2022, the First Decline in a Decade
- The Wall Street Journal Interactive Edition
-
10-Q: REGENERON PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Amgen Seeks to Monopolize Nature
- The Wall Street Journal Interactive Edition
-
Regeneron, Sanofi Look for Billions From COPD Drug
- The Wall Street Journal Interactive Edition
-
Regeneron Borrows From Big Pharma Playbook
- The Wall Street Journal Interactive Edition
-
LOOMIS SAYLES & CO L P Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Freedom Day Solutions, LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of MCDONALD CAPITAL INVESTORS INC/CA
- GuruFocus.com
-
Top 5 4th Quarter Trades of Pacer Advisors, Inc.
- GuruFocus.com
-
Top 5 4th Quarter Trades of Tom Gayner
- GuruFocus.com
-
SEIZERT CAPITAL PARTNERS, LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Covenant Asset Management, LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Old Port Advisors Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
Nasdaq Rises, as Dow and S&P 500 Slip
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on REGN
-
Regeneron Announces Investor Conference Presentations
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com